NCT04012320已完成不适用
Efficacy and Safety on the Use of Bisphosphonates in Paediatrics
Centre Hospitalier Universitaire de Nīmes1 个研究点 分布在 1 个国家目标入组 99 人开始时间: 2018年10月31日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 99
- 试验地点
- 1
- 主要终点
- pain frequency
研究概览
简要总结
The investigators suppose that the impact of bisphosphonate therapy is beneficial on the bone during the growth period with few adverse events.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- — 至 18 Years（Child, Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •be under 18 years of age
- •have been treated by intravenous bisphosphonates for primary or secondary osteoporosis
排除标准
- •be over 18 years of age
结局指标
主要结局
pain frequency
时间窗: 2 years
(never, occasional, regular)
fracture rates
时间窗: 2 years
(numbers)
bone mineral density
时间窗: 2 years
(Z-score)
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Examination of utility of bisphosphonate to osteoporosis by ovarian insufficiency after gynecologic cancer treatmentOsteoporosis after gynecologic cancer treatmentJPRN-UMIN000005665Gifu University50
招募中
3 期
Bisphosphonate Use to Mitigate Bone Loss Secondary to Bariatric SurgeryBone LossNCT04922333Wake Forest University Health Sciences200
Unknown
不适用
Radiographic Influences of Bisphosphonate Treatment on FemurFemur FractureNCT01969279Tomidahama Hospital100
已完成
4 期
Bisphosphonate Therapy for Osteogenesis ImperfectaPaget Disease of BoneOsteoporosisOsteogenesis ImperfectaNCT00159419Indiana University School of Medicine18
已完成
4 期
Effect of Zoledronic Acid on Bone Metabolism in Patients With Bone Metastasis and Prostate or Breast CancerBone MetastasisBreast CancerProstate CancerNCT00334139Novartis Pharmaceuticals411